NewAmsterdam Net Working Capital from 2010 to 2025

NAMS Stock   21.00  0.09  0.43%   
NewAmsterdam Pharma Net Working Capital yearly trend continues to be comparatively stable with very little volatility. Net Working Capital is likely to outpace its year average in 2025. From the period from 2010 to 2025, NewAmsterdam Pharma Net Working Capital quarterly data regression had mean square error of 36590 T and mean deviation of  211,613,352. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
756.5 M
Current Value
794.3 M
Quarterly Volatility
275.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NewAmsterdam Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NewAmsterdam Pharma's main balance sheet or income statement drivers, such as Net Interest Income of 17.7 M, Interest Income of 17.7 M or Depreciation And Amortization of 59.2 K, as well as many indicators such as Price To Sales Ratio of 33.94, Dividend Yield of 0.0 or PTB Ratio of 3.36. NewAmsterdam financial statements analysis is a perfect complement when working with NewAmsterdam Pharma Valuation or Volatility modules.
  
Check out the analysis of NewAmsterdam Pharma Correlation against competitors.
For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

Latest NewAmsterdam Pharma's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of NewAmsterdam Pharma over the last few years. It is NewAmsterdam Pharma's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NewAmsterdam Pharma's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

NewAmsterdam Net Working Capital Regression Statistics

Arithmetic Mean141,868,484
Coefficient Of Variation194.51
Mean Deviation211,613,352
Median(3,589,000)
Standard Deviation275,945,431
Sample Variance76145.9T
Range797.9M
R-Value0.74
Mean Square Error36590T
R-Squared0.55
Significance0.001
Slope43,043,333
Total Sum of Squares1142188.2T

NewAmsterdam Net Working Capital History

2025794.3 M
2024756.5 M
2023296.9 M
2022412.7 M
202149 M

About NewAmsterdam Pharma Financial Statements

NewAmsterdam Pharma shareholders use historical fundamental indicators, such as Net Working Capital, to determine how well the company is positioned to perform in the future. Although NewAmsterdam Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in NewAmsterdam Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on NewAmsterdam Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Working Capital756.5 M794.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NewAmsterdam Stock Analysis

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.